SE423813B - PROCEDURE FOR THE PREPARATION OF 1,5-DISUBSTITUTED PYRROLIDONS WITH THERAPEUTICAL PROPERTIES - Google Patents

PROCEDURE FOR THE PREPARATION OF 1,5-DISUBSTITUTED PYRROLIDONS WITH THERAPEUTICAL PROPERTIES

Info

Publication number
SE423813B
SE423813B SE7708642A SE7708642A SE423813B SE 423813 B SE423813 B SE 423813B SE 7708642 A SE7708642 A SE 7708642A SE 7708642 A SE7708642 A SE 7708642A SE 423813 B SE423813 B SE 423813B
Authority
SE
Sweden
Prior art keywords
pyrrolidons
disubstituted
procedure
preparation
therapeutical properties
Prior art date
Application number
SE7708642A
Other languages
Swedish (sv)
Other versions
SE7708642L (en
Inventor
A J Nelson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SE7708642L publication Critical patent/SE7708642L/en
Publication of SE423813B publication Critical patent/SE423813B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7708642A 1976-08-06 1977-07-27 PROCEDURE FOR THE PREPARATION OF 1,5-DISUBSTITUTED PYRROLIDONS WITH THERAPEUTICAL PROPERTIES SE423813B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US71236276A 1976-08-06 1976-08-06

Publications (2)

Publication Number Publication Date
SE7708642L SE7708642L (en) 1978-02-07
SE423813B true SE423813B (en) 1982-06-07

Family

ID=24861795

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7708642A SE423813B (en) 1976-08-06 1977-07-27 PROCEDURE FOR THE PREPARATION OF 1,5-DISUBSTITUTED PYRROLIDONS WITH THERAPEUTICAL PROPERTIES

Country Status (31)

Country Link
JP (2) JPS5321159A (en)
AR (1) AR217080A1 (en)
AT (1) AT362887B (en)
AU (1) AU508007B2 (en)
BE (1) BE857506A (en)
BG (1) BG31073A3 (en)
CA (1) CA1077948A (en)
CH (1) CH624934A5 (en)
CS (1) CS221269B2 (en)
DD (2) DD143768A5 (en)
DE (1) DE2735904A1 (en)
DK (1) DK352077A (en)
ES (2) ES461388A1 (en)
FI (1) FI70009C (en)
FR (1) FR2369260A1 (en)
GB (2) GB1556569A (en)
GR (1) GR68688B (en)
HU (1) HU180273B (en)
IE (1) IE45505B1 (en)
IL (1) IL52615A (en)
LU (1) LU77936A1 (en)
NL (1) NL7708637A (en)
NO (1) NO772752L (en)
NZ (1) NZ184806A (en)
PH (1) PH17398A (en)
PL (2) PL200124A1 (en)
PT (1) PT66891B (en)
SE (1) SE423813B (en)
SU (3) SU703016A3 (en)
YU (1) YU192577A (en)
ZA (1) ZA774704B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5695569A (en) * 1979-12-27 1981-08-03 Canon Inc Forming method for bar lens sphere face
US4321201A (en) * 1980-09-22 1982-03-23 E. I. Du Pont De Nemours And Company Optically active tert-alkyl 7-(2-oxo-5-carbonyloxypyrrolidinyl) heptanoates
JPS59137224A (en) * 1983-01-25 1984-08-07 Mitsubishi Electric Corp Feed voltage compensator for electric railroad
IL141120A0 (en) * 2000-01-31 2002-02-10 Pfizer Prod Inc Use of prostaglandin (pge2) receptor 4 (epa) selective agonists for the treatment of acute and chronic renal failure
AU2001290250A1 (en) * 2000-09-21 2002-04-02 Ono Pharmaceutical Co. Ltd. Ep4 receptor agonists containing 8-azaprostaglandin derivatives as the active ingredient
MXPA03004623A (en) * 2000-11-27 2003-09-05 Pfizer Prod Inc Ep4 receptor selective agonists in the treatment of osteoporosis.
KR100826866B1 (en) * 2001-07-23 2008-05-06 오노 야꾸힝 고교 가부시키가이샤 Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient
DE60307607T2 (en) * 2002-03-18 2007-08-09 Pfizer Products Inc., Groton USE OF SELECTIVE EP4 RECEPTOR AGONISTS FOR THE TREATMENT OF DISEASES
US6573294B1 (en) * 2002-05-14 2003-06-03 Allergan, Inc. 8-azaprostaglandin analogs as agents for lowering intraocular pressure
JP4582456B2 (en) * 2003-01-21 2010-11-17 小野薬品工業株式会社 8-Azaprostaglandin derivatives and pharmaceutical use thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1386146A (en) * 1972-05-03 1975-03-05 Ici Ltd Cyclopentane derivatives
JPS511460A (en) * 1974-06-24 1976-01-08 Tanabe Seiyaku Co 22 piroridonjudotaino seiho
JPS514166A (en) * 1974-06-28 1976-01-14 Tanabe Seiyaku Co 22PIRORIDONJUDOTAINO SEIHO
US3975399A (en) * 1974-08-06 1976-08-17 E. I. Du Pont De Nemours And Company 1,5-Disubstituted-2-pyrrolidinones, -3-pyrrolin-2-ones, and -4-pyrrolin-2-ones
DE2528664A1 (en) * 1975-06-27 1977-01-13 Hoechst Ag PYRROLIDONE AND THE METHOD FOR MANUFACTURING THEIR

Also Published As

Publication number Publication date
FR2369260B1 (en) 1982-02-12
HU180273B (en) 1983-02-28
CH624934A5 (en) 1981-08-31
DE2735904A1 (en) 1978-02-09
PL200124A1 (en) 1978-05-22
FI70009B (en) 1986-01-31
JPS585196B2 (en) 1983-01-29
FI70009C (en) 1986-09-12
GB1556569A (en) 1979-11-28
JPS5555161A (en) 1980-04-22
NO772752L (en) 1978-02-07
DD143768A5 (en) 1980-09-10
CA1077948A (en) 1980-05-20
IL52615A (en) 1981-09-13
PL112931B1 (en) 1980-11-29
ES461388A1 (en) 1978-12-01
AU2751577A (en) 1979-02-08
FR2369260A1 (en) 1978-05-26
SU818480A3 (en) 1981-03-30
YU192577A (en) 1983-04-30
FI772376A (en) 1978-02-07
IE45505B1 (en) 1982-09-08
NL7708637A (en) 1978-02-08
NZ184806A (en) 1980-04-28
ZA774704B (en) 1978-06-28
IL52615A0 (en) 1977-10-31
DK352077A (en) 1978-02-07
SU703016A3 (en) 1979-12-05
ES471349A1 (en) 1979-09-16
AT362887B (en) 1981-06-25
GB1556570A (en) 1979-11-28
PT66891A (en) 1977-09-01
BG31073A3 (en) 1981-10-15
CS221269B2 (en) 1983-04-29
LU77936A1 (en) 1978-04-27
PT66891B (en) 1979-01-26
PH17398A (en) 1984-08-08
IE45505L (en) 1978-02-06
DD136135A5 (en) 1979-06-20
AU508007B2 (en) 1980-03-06
GR68688B (en) 1982-02-01
JPS5531147B2 (en) 1980-08-15
SU850000A3 (en) 1981-07-23
SE7708642L (en) 1978-02-07
AR217080A1 (en) 1980-02-29
JPS5321159A (en) 1978-02-27
ATA579477A (en) 1980-11-15
BE857506A (en) 1978-02-06

Similar Documents

Publication Publication Date Title
NO803851L (en) PROCEDURE FOR THE PREPARATION OF 4,1`, 6`-TRICLOR-4,1`, 6`-TRIDEOXY-GALACTOSUCROSE
SE435059B (en) PROCEDURE FOR THE PREPARATION OF DIVESTUATED 1-PHENYL-2-ALKYLAMINOETHANOL COMPOUNDS WITH DIVEROCOCYLIC GROUPS
NO146394C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF 1,2-DIPHENYL-3- (IMIDAZOL-1-YL) -PROPAN-2-OLES WITH THERAPEUTICAL EFFECT
NO774404L (en) PROCEDURE FOR THE PREPARATION OF DIMETHYLETER
AR224095A1 (en) PROCEDURE FOR THE PREPARATION OF NEW DERIVATIVES OF DITIOL-1,2 TIONA-3
NO148959C (en) PROCEDURE FOR THE PREPARATION OF TUMOR-EFFECTIVE ANTACYCYLICOSIDE ANTIBIOTICS, MA MA 144
SE441354B (en) PROCEDURE FOR THE PREPARATION OF META-PHENOXIBENZALDEHYDE
SE435387B (en) PROCEDURE FOR THE PREPARATION OF ANTRACYCLING GYCOSIDES
NO143992C (en) PROCEDURE FOR THE PREPARATION OF HEXANITROSTILBEN
SE7604475L (en) PROCEDURE FOR THE PREPARATION OF 1,1,1-TRIARYL-ALKYLAMINES
NO151365C (en) PROCEDURE FOR THE PREPARATION OF 4-HALOGEN-DIHYDROPYRANE DERIVATIVES.
SE423813B (en) PROCEDURE FOR THE PREPARATION OF 1,5-DISUBSTITUTED PYRROLIDONS WITH THERAPEUTICAL PROPERTIES
NO770619L (en) PROCEDURES FOR THE PREPARATION OF 2,3-SUBSTITUTED-5,6-CONDENSED 4 (2H) -AMINOALCOXY-PYRANONS WITH HYPOTENSIVE, ANTI-ISCHAEMIA AND ANTI-COUGHING EFFECT
SE436026B (en) PROCEDURE FOR THE PREPARATION OF 13,14-DEHYDROPROSTAGLANDINES
RO75589A (en) PROCEDURE FOR THE PREPARATION OF 2,6-METHAN-2H-1-BENZOXOXINE
SE434263B (en) PROCEDURE FOR THE PREPARATION OF CHLORETYL NITROSOCARBAMIDS WITH ANTITUMUM EFFECTS
NO771870L (en) PROCEDURE FOR THE PREPARATION OF 3,4-DIHYDRO-2-METHYL-4-OXO-2H-1,2-BENZOTIAZINE-3-CARBOXYLIC ACID-1,1-DIOXYDE
SE7707471L (en) PROCEDURE FOR THE PREPARATION OF 5-M-TOLYLOXIURACIL
SE7804878L (en) PROCEDURE FOR THE PREPARATION OF 1,2-DICHLORETANE
SE7707125L (en) PROCEDURE FOR THE PREPARATION OF 7- (ALFA- (2,3, - DIHYDRO-2-OXO-1H- BENSIMIDAZOLE -1- YLCARBOMYL-AMINO) ARYLACETAMIDO) CEPHALASPORINES
SE7712218L (en) PROCEDURE FOR THE PREPARATION OF 4A-ARYLOCTAHYDRO-1H-2-PYRINDINES
NO771263L (en) PROCEDURES FOR THE PREPARATION OF INDOL-NAFTYRIDINE DERIVATIVES
SE428922B (en) PROCEDURE FOR THE PREPARATION OF 13,14-DIHYDRO-11-DIOXY-PROSTAGLANDINES
SE7601605L (en) PROCEDURE FOR THE PREPARATION OF 1 ALFA, 25-DIHYDROXY-CHOLCALCIFEROL
SE432765B (en) PROCEDURE FOR THE PREPARATION OF 2,9-DIOXATRICYCLO / 4,3,1,0? 723? 72,? 727 / DECAN